These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 36875133)

  • 21. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.
    Yoshimura T; Sonoda KH; Sugahara M; Mochizuki Y; Enaida H; Oshima Y; Ueno A; Hata Y; Yoshida H; Ishibashi T
    PLoS One; 2009 Dec; 4(12):e8158. PubMed ID: 19997642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic changes of aqueous humor in proliferative diabetic retinopathy patients treated with different intravitreal anti-VEGF agents.
    Chen H; Qiu B; Gao G; Chen Y; Min H; Wu Z
    Exp Eye Res; 2022 Mar; 216():108942. PubMed ID: 35032522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated VEGF receptor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for predicting the treatment timing and monitoring response.
    Davuluri G; Espina V; Petricoin EF; Ross M; Deng J; Liotta LA; Glaser BM
    Arch Ophthalmol; 2009 May; 127(5):613-21. PubMed ID: 19433709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of angiogenic factor Cysteine-rich 61 levels in vitreous of patients with proliferative diabetic retinopathy.
    You JJ; Yang CM; Chen MS; Yang CH
    Retina; 2012 Jan; 32(1):103-11. PubMed ID: 21822163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry.
    Wang H; Feng L; Hu J; Xie C; Wang F
    Exp Eye Res; 2013 Mar; 108():110-9. PubMed ID: 23276812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study.
    Zeng L; Zhou M; Wang X; Long X; Ye M; Yuan Y; Tan W
    BMC Ophthalmol; 2023 Mar; 23(1):94. PubMed ID: 36899334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Proteomics Analysis of Vitreous Humor from Diabetic Retinopathy Patients.
    Loukovaara S; Nurkkala H; Tamene F; Gucciardo E; Liu X; Repo P; Lehti K; Varjosalo M
    J Proteome Res; 2015 Dec; 14(12):5131-43. PubMed ID: 26490944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of sex steroid concentration levels in the vitreous and serum of patients with vitreoretinal diseases.
    Nishikawa Y; Morishita S; Horie T; Fukumoto M; Sato T; Kida T; Oku H; Sugasawa J; Ikeda T; Nakamura K
    PLoS One; 2017; 12(7):e0180933. PubMed ID: 28704441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
    Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics of Vitreous Humor Reveals PPARA, RXR, and LXR Are Possible Upstream Regulators of Proliferative Diabetic Retinopathy.
    Li S; Jin E; Shi X; Cai Y; Zhang H; Zhao M
    Front Med (Lausanne); 2021; 8():724695. PubMed ID: 34485353
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B; Li T; Chen H; Xu X; Zheng Z
    Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomics of vitreous humor of patients with exudative age-related macular degeneration.
    Koss MJ; Hoffmann J; Nguyen N; Pfister M; Mischak H; Mullen W; Husi H; Rejdak R; Koch F; Jankowski J; Krueger K; Bertelmann T; Klein J; Schanstra JP; Siwy J
    PLoS One; 2014; 9(5):e96895. PubMed ID: 24828575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
    Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INCREASED COMPLEMENT LEVELS IN HUMAN VITREOUS ASPIRATES OF PROLIFERATIVE DIABETIC RETINOPATHY AND RETINAL DETACHMENT EYES.
    Manoharan N; Patnaik JL; Olson JL
    Retina; 2019 Nov; 39(11):2212-2218. PubMed ID: 30148749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of preoperative vitreous IL-8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy.
    Petrovič MG; Korošec P; Košnik M; Hawlina M
    Acta Ophthalmol; 2010 Dec; 88(8):e311-6. PubMed ID: 21073666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EPIRETINAL MEMBRANES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Effect on Outcomes of Anti-vascular Endothelial Growth Factor Therapy.
    Karaca EE; Kepez Yldz B; Çubuk MÖ; Özdek Ş
    Retina; 2015 Aug; 35(8):1540-6. PubMed ID: 25768251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative proteomics of proliferative diabetic retinopathy in people with Type 2 diabetes highlights the role of inflammation, visual transduction, and extracellular matrix pathways.
    Sen S; Udaya P; Jeya Maheshwari J; Kohli P; Parida H; Kannan NB; Ramasamy K; Dharmalingam K
    Indian J Ophthalmol; 2023 Aug; 71(8):3069-3079. PubMed ID: 37530283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy.
    Rezzola S; Nawaz IM; Cancarini A; Ravelli C; Calza S; Semeraro F; Presta M
    Angiogenesis; 2017 Nov; 20(4):629-640. PubMed ID: 28905243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.
    Liisborg C
    Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.